New Zealand Data Sheet Arrow - Sertraline - …
New Zealand Data Sheet Arrow - Sertraline Sertraline hydrochloride Tablets 50mg & 100mg Presentation Arrow - Sertraline Tablets 50mg: White to …
Download New Zealand Data Sheet Arrow - Sertraline - …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
VENLAFAXINE - neiglobal.com
cdn.neiglobal.com786 VENLAFAXINE (continued) Life-Threatening or Dangerous Side Effects • Rare seizures • Rare induction of hypomania • Rare activation of suicidal ideation and
HIGHLIGHTS OF PRESCRIBING INFORMATION than …
labeling.bayerhealthcare.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use YAZ safely and effectively. See full …
Mental Status Exam Checklist - Beat the Boards!
www.beattheboards.comBeat The Boards! Mental Status Exam Items American Physician Institute for Advanced Professional Studies LLC 877-225-8384 GENERAL APPEARANCE • Alertness:
Patient Education SERTRALINE - ORAL
www.doctorsuh.comPatient Education SERTRALINE - ORAL IMPORTANT NOTE: The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional.
DSM-5: What Counselors Need to Know
www.lacounseling.orgDSM-5: What Counselors Need to Know Gary G. Gintner, Ph.D., LPC Louisiana State University Baton Rouge, LA [email protected]
2016.05.20 Fluox DS - Medsafe Home Page
www.medsafe.govt.nzPage 2 of 11 • Premenstrual dysphoric disorder - a severe form of PMS Diagnosis of PMDD: The essential features of PMDD are clear and established cyclicity of symptoms